Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...
On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the changes to F...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...